Marta Mendiola has a BachelorĀ“s Degree in Chemistry, and a Biochemistry and Molecular Biology phD by Autonomous University of Madrid (UAM). She develops her work based in Hospital La Paz Institute for Health Research (IdiPAZ), focused on the identification of biomarkers associated to diagnosis, prognosis ad response to treatment prediction in cancer, mainly in gynecological tumors and sarcomas.

She is also part of the Molecular Pathology Section, where coordinates biomarker determination that are implemented in routine, due to their utility in the management of patients.

She is member of the Spanish (ASEICA) and the European (EACR) cancer research societies, and an active member of the Spanish research groups in sarcomas (GEIS), and in ovarian and gynecological malignancies (GEICO).